Suppr超能文献

相似文献

2
Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
Biomacromolecules. 2012 Apr 9;13(4):982-91. doi: 10.1021/bm201639c. Epub 2012 Mar 30.
3
Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
J Med Chem. 2005 Jun 2;48(11):3729-35. doi: 10.1021/jm040187v.
4
Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
Anticancer Drugs. 2008 Feb;19(2):143-9. doi: 10.1097/CAD.0b013e3282f28842.
5
Design considerations for PAMAM dendrimer therapeutics.
Bioorg Med Chem Lett. 2013 May 15;23(10):2872-5. doi: 10.1016/j.bmcl.2013.03.088. Epub 2013 Apr 1.
8
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
J Biomed Nanotechnol. 2015 Aug;11(8):1431-41. doi: 10.1166/jbn.2015.2077.
9
Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
Mol Pharm. 2012 Sep 4;9(9):2669-2676. doi: 10.1021/mp3002232. Epub 2012 Aug 7.
10
Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.
Bioorg Med Chem. 2011 Apr 15;19(8):2557-64. doi: 10.1016/j.bmc.2011.03.019. Epub 2011 Mar 12.

引用本文的文献

1
Dendrimer-Coated Gold Nanoparticles for Efficient Folate-Targeted mRNA Delivery In Vitro.
Pharmaceutics. 2021 Jun 17;13(6):900. doi: 10.3390/pharmaceutics13060900.
2
Targeting Groups Employed in Selective Dendrons and Dendrimers.
Pharmaceutics. 2018 Nov 8;10(4):219. doi: 10.3390/pharmaceutics10040219.
3
Dendrimer Prodrugs.
Molecules. 2016 May 31;21(6):686. doi: 10.3390/molecules21060686.
5
Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
Mol Pharm. 2012 Sep 4;9(9):2669-2676. doi: 10.1021/mp3002232. Epub 2012 Aug 7.
6
Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.
Arthritis Rheum. 2011 Sep;63(9):2671-80. doi: 10.1002/art.30459.
7
Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.
Bioorg Med Chem. 2011 Apr 15;19(8):2557-64. doi: 10.1016/j.bmc.2011.03.019. Epub 2011 Mar 12.

本文引用的文献

1
Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
Biomaterials. 2009 Oct;30(29):5757-66. doi: 10.1016/j.biomaterials.2009.07.020. Epub 2009 Jul 29.
2
Nanocarriers as an emerging platform for cancer therapy.
Nat Nanotechnol. 2007 Dec;2(12):751-60. doi: 10.1038/nnano.2007.387.
3
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid.
J Control Release. 2008 May 8;127(3):239-48. doi: 10.1016/j.jconrel.2008.02.002. Epub 2008 Feb 15.
5
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
Chem Biol. 2007 Jan;14(1):107-15. doi: 10.1016/j.chembiol.2006.11.015.
8
Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.
J Med Chem. 2005 Sep 22;48(19):5892-9. doi: 10.1021/jm0401863.
9
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
J Pharm Sci. 2005 Oct;94(10):2135-46. doi: 10.1002/jps.20457.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验